Improved decision making for older women with early breast cancer
Published: 2 Oct 2020
Views: 392
Prof Lynda Wyld - University of Sheffield, Sheffield, UK
Prof Lynda Wyld speaks to ecancer about her presentation at the EBCC 2020 online congress.
She speak about the age-gap study which has been running since 2013, designed to understand if primary endocrine therapy (omitting surgery) was safe for older women with breast cancer.
Prof Wyld spoke about the design of the trial, and analysed some of the results. She also discussed how quality of life was taken into account when looking at the decision making process for surgery.
Related Videos
Updates in geriatric oncology from SIOG 2020
Dr Siri Rostoft - Oslo University Hospital, Oslo, Norway
25 Nov 2020
Treating elderly cancer patients during the COVID-19 pandemic
Dr Anna Mislang - Flinders Private Hospital, Bedford Park, Australia
30 Oct 2020
Highlights from EBCC-12
Prof Nadia Harbeck - EBCC Conference Chair
23 Oct 2020
The management of endocrine therapy in young patients with breast cancer
Dr Olivia Pagani - European School of Oncology, Milan, Italy
8 Oct 2020
Adapting care for older cancer patients during the COVID-19 pandemic
Dr Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK
7 Aug 2020
Prophylactic mastectomy and breast surveillance
Dr. Viviana Galimberti - European Institute of Oncology, Milan, Italy
22 Jul 2020
An improved procedure for breast conservation surgery
Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India
17 Jul 2020
COVID-19: Management of non-small cell lung cancer patients during the coronavir...
Dr Heather Wakelee - Stanford University, Stanford, USA
12 May 2020
Providing practical tips for completing geriatric assessments
Dr Melissa Loh - Rochester Medical Center, Rochester, USA
5 Dec 2019
